Elevated serum levels of interleukin-6 (IL-6) are associated with an increased incidence and progression of AMD, whereas the presence of interleukin-8 (IL-8) decreases the development of neovascularization and apparently confers a protective effect. This evidence concerns the gene CXCL8 and age-related macular degeneration.